Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Zevia PBC reported the fourth quarter ended December 31, 2022 results: revenue $35.4 million, net income $6.2 million, EPS $0.10 per diluted share. Guidance initiated.
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $35.4 million
- Net income
- $6.2 million
- EPS
- $0.10 per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Net sales increased 3.5% year-over-year to $35.4 million • Unit volume decreased 8.7% year-over-year to 2.7 million equivalized cases • Gross profit margin of 44.3%, the strongest gross margin percent in 2022 • Net loss was $6.2 million, including $3.1 million of non-cash equity-based compensation expense • Adjusted EBITDA loss was $2.9 million (1) • Loss per share was $0.10 per diluted share to Zevia’s Class A common stockholders
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Zevia PBC reported the full year ended December 31, 2022 results: revenue $163.2 million, net income $47.6 million, EPS $0.81 per diluted share. Guidance initiated.
- Period
- the full year ended December 31, 2022
- Revenue
- $163.2 million
- Net income
- $47.6 million
- EPS
- $0.81 per diluted share
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Net sales increased 18.1% year-over-year to $163.2 million • Unit volume increased 10.7% year-over-year to 13.6 million equivalized cases • Gross profit margin of 42.9% • Net loss was $47.6 million, including $26.9 million of non-cash equity-based compensation expense • Adjusted EBITDA loss was $19.6 million (1) • Loss per share was $0.81 per diluted share to Zevia’s Class A common stockholders
View on SEC.gov